Durham – North Carolina, USA: SOPHiA GENETICS, leader in Data-Driven Medicine, today announced from the Personalized Medicine World Congress (PMWC) at Duke University that the company has opened operations in Boston to meet the burgeoning demand across the United States. SOPHiA AI (SOPHiA) is the most widely used technology for genomic analysis, adopted by hundreds […]
TORONTO–Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to cooperate in the development of Synaptic Density Biomarker Imaging (“SDI”). SDI promises to provide an important new tool in understanding neurodegenerative diseases such as Alzheimer’s […]
Genestack’s new module helps biologists interrogate omics data Answering basic questions about drug targets requires having all transcriptomics data in one place, properly annotated by curators, processed and visualised by bioinformaticians. This is costly to set up and maintain; not doing it delays decision making and puts unnecessary strain on computational biology resources. Misha Kapushesky, […]
Cambridge, United Kingdom – Congenica, the global diagnostic decision support platform provider, today announced it has entered into an agreement with a new strategic partner Digital China Health Technologies Cooperation Limited (DCHealth), further extending Congenica’s commitment to the Chinese market. The new partnership will see Congenica develop a version of its Sapientia™ platform designed to enable clinicians and […]
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has been awarded a new funded cooperative agreement, for $250,000 per year for up to two […]
Cambridge, Mass. and Athens, Greece. Seven Bridges, the leading biomedical data platform and analytics company, and e-NIOS, a biological knowledge discovery start-up, announced a strategic partnership towards data-driven discovery of biomarker signatures. Derivation of robust biomarkers from next generation sequencing and multi-omic data is currently a major bottleneck in precision medicine initiatives. This bottleneck continues to limit […]
Cambridge, Mass. Seven Bridges, the leading biomedical data platform and analytics company, today announced the launch of the new Kids First Data Resource Portal with the Gabriella Miller Kids First Data Resource Center (DRC) at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia. The Gabriella Miller Kids First Data Resource Center is a new, collaborative, pediatric research […]
Simulations Plus announced today that it received an extension to its funded research collaboration with the FDA to develop the GastroPlus OCAT model. New functionality to mechanistic ocular absorption model in GastroPlus™ supports FDA’s future Innovation Initiative Simulations Plus, Inc. (Nasdaq:SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and […]
Certara’s QSTS division is actively involved in several international partnerships, developing novel modeling and simulation approaches to solve toxicological issues PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced that it has appointed Mark Holbrook, PhD, to the newly-created position of vice president of quantitative […]
Co-sell partnership to provide unparalleled access to Microsoft’s Enterprise customers Eagle Genomics solution enables assessment of viability, efficacy and safety of enterprise branded products Driving digital reinvention of life sciences using artificial intelligence to map the microbiome LONDON, September 2018 - Eagle Genomics joins a specialised group of high-growth startups, earning co-sell status as part […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
